News Archive

The collaborative effort put in place for the Lung-MAP is a game changing process. It will revolutionize the way clinical trials are conducted, leading the way to more rapid drug development and approval for patients. For the first time a trial will begin with the focus on the patient and personalize their therapy to their tumor mutations rather than the reverse.